The FDA has issued final guidance on “Providing Regulatory Submissions in Electronic Format--Drug Establishment Registration and Drug Listing.'' As of June 1, 2009, FDA will only accept electronic submissions of drug establishment registration and drug listing information, unless a waiver is granted. This document provides guidance to manufacturers, repackers, and relabelers on the types of information to include for purposes of drug establishment registration and drug listing and on how to prepare and submit the information in an electronic format that FDA can process, review, and archive.
- How-to guide How-to guide: How to identify suspicious activity and make a Suspicious Activity Report (SAR) (USA)
- Checklist Checklist: What to consider when reviewing terms and conditions for the purchase of goods and services (buyer’s perspective) – B2B (UK)
- Checklist Checklist: Anti-bribery and corruption procedures (UK)